NexImmune raises $23mm through Series A round
- Gene Therapy, Cell Therapy
- Nanotechnology, Chips, etc.
- Private Placement
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.